NovoCure: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

ST. HELIER, Jersey (AP) — ST. HELIER, Jersey (AP) — NovoCure Ltd. (NVCR) on Thursday reported a loss of $47.1 million in its fourth quarter.

The St. Helier, Jersey-based company said it had a loss of 45 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 53 cents per share.

The oncology drug developer posted revenue of $133.8 million in the period.

For the year, the company reported a loss of $207 million, or $1.95 per share. Revenue was reported as $509.3 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVCR at https://www.zacks.com/ap/NVCR

Advertisement

Recommended Stories